Fludarabine Phosphate, Low-Dose Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer

ClinicalTrials.gov ID: NCT00005799

Public ClinicalTrials.gov record NCT00005799. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced May 21, 2026, 12:54 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Low-Dose TBI and Fludarabine Followed by Unrelated Donor Stem Cell Transplantation for Patients With Hematologic Malignancies and Renal Cell Carcinoma - A Multi-center Trial

Study identification

NCT ID: NCT00005799
Recruitment status: Completed
Study type: Interventional
Phase: Not applicable
Lead sponsor: Fred Hutchinson Cancer Center; Other
Enrollment: 55 participants

Conditions and interventions

Conditions

Interventions

allogeneic bone marrow transplantation Procedure
cyclosporine Drug
fludarabine phosphate Drug
laboratory biomarker analysis Other
mycophenolate mofetil Drug
nonmyeloablative allogeneic hematopoietic stem cell transplantation Procedure
peripheral blood stem cell transplantation Procedure
pharmacological study Other
therapeutic allogeneic lymphocytes Biological
total-body irradiation Radiation

Procedure · Drug · Other + 2 more

Eligibility (public fields only)

Age range: Not listed
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Oct 31, 1999
Primary completion: Jun 30, 2002
Completion: Not listed
Last update posted: Sep 9, 2019

Started 1999

United States locations

U.S. sites: 6
U.S. states: 5
U.S. cities: 6

Facility	City	State	ZIP	Site status
City of Hope Medical Center	Duarte	California	91010	—
Stanford University Hospitals and Clinics	Stanford	California	94305	—
University of Colorado	Denver	Colorado	80217-3364	—
Baylor University Medical Center	Dallas	Texas	75246	—
Huntsman Cancer Institute/University of Utah	Salt Lake City	Utah	84112	—
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium	Seattle	Washington	98109	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT00005799, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Sep 9, 2019 · Synced May 21, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00005799 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →